Pilabactam
![]() | |
| Clinical data | |
|---|---|
| Other names | ANT3310 |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C6H9FN2O5S |
| Molar mass | 240.21 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Pilabactam is an beta-lactamase inhibitor that is being evaluated by Antabio as an antiinfective.[1][2][3]
Chemistry
The first in class non-β-lactam β-lactamase inhibitor avibactam contains a strained urea functional group within the diazabicyclooctane (DBO) ring system. This strained urea acts as a warhead that reacts with the active site serine residue in β-lactamases. Other drugs in this class include relebactam, durlobactam, nacubactam and zidebactam.[2] However none of these are active against carbapenem-resistant Acinetobacter baumannii. (CRAB). Pilabactam contains a fluorine atom that replaces a carboxamide group in the other DBOs and restores CRAB sensitivity.[2]
See also
References
- ↑ "MEM ANT 3310". AdisInsight. Springer Nature Switzerland AG.
- 1 2 3 Davies DT, Leiris S, Zalacain M, Sprynski N, Castandet J, Bousquet J, et al. (December 2020). "Discovery of ANT3310, a Novel Broad-Spectrum Serine β-Lactamase Inhibitor of the Diazabicyclooctane Class, Which Strongly Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacterales and Acinetobacter baumannii". Journal of Medicinal Chemistry. 63 (24): 15802–15820. doi:10.1021/acs.jmedchem.0c01535. PMID 33306385.
- ↑ Rodríguez-Pallares S, Outeda-García M, Lence E, Rodríguez-Coello A, González-Pinto L, Guijarro-Sánchez P, et al. (April 2026). "Disarming carbapenemase-producing Acinetobacter baumannii: high potency of the novel therapeutic combination of meropenem and the innovative diazabicyclooctane β-lactamase inhibitor pilabactam (formerly ANT3310)". Antimicrobial Agents and Chemotherapy. 70 (4) e0169125. doi:10.1128/aac.01691-25. PMC 13041389. PMID 41711564.
